M. Wagner

Most-cited papers

1. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration

   H. Möllmann, M. Wagner, B. Meibohm, G. Hochhaus +6 more

   1998European Journal of Clinical Pharmacology72 citations

   Semantic Scholar

   Save

2. Single‐Dose and Steady‐State Pharmacokinetic and Pharmacodynamic Evaluation of Therapeutically Clinically Equivalent Doses of Inhaled Fluticasone Propionate and Budesonide, Given as Diskus® or Turbohaler® Dry‐Powder Inhalers to Healthy Subjects

   H. Möllmann, M. Wagner, S. Krishnaswami, H. Dimova +10 more

   2001Journal of clinical pharmacology42 citations

   Semantic Scholar

   Save

3. Dependency of Cortisol Suppression on the Administration Time of Inhaled Corticosteroids

   B. Meibohm, G. Hochhaus, S. Rohatagi, H. Möllmann +5 more

   1997Journal of clinical pharmacology36 citations

   Semantic Scholar

   Save

4. Pharmacokinetic/Pharmacodynamic Evaluation of Systemic Effects of Flunisolide after Inhalation

   H. Möllmann, H. Derendorf, Jürgen Barth, B. Meibohm +6 more

   1997Journal of clinical pharmacology31 citations

   Semantic Scholar

   Save

5. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.

   Bernd Meibohm, H. Derendorf, H. Möllmann, P. Fröhlich +5 more

   1999International journal of clinical pharmacology and therapeutics21 citations

   Semantic Scholar

   Save

6. The clinical pharmacology of fluticasone propionate

   B. Meibohm, H. Möllmann, M. Wagner, G. Hochhaus +2 more

   199821 citations

   Semantic Scholar

   Save

7. A Pharmacokinetic/Pharmacodynamic Approach to Predict the Cumulative Cortisol Suppression of Inhaled Corticosteroids

   B. Meibohm, G. Hochhaus, H. Möllmann, J. Barth +4 more

   1999Journal of pharmacokinetics and biopharmaceutics18 citations

   Semantic Scholar

   Save

8. Genetic polymorphisms and drug interactions modulating CYP 2 D 6 and CYP 3 A activities have a major effect on oxycodone analgesic efficacy and safetybph

   C. Samer, Y. Daali, M. Wagner, G. Hopfgartner +6 more

   20101 citations

   Semantic Scholar

   Save

9. Cortisol suppression after oral delivery of budesonide in pH-modified release capsules*

   G. Hochhaus, M. Wagner, H. Möllmann, A. Tromm +4 more

   19981 citations Open access

   Semantic Scholar

   Save

10. Release characteristics of budesonide from pH-modified release capsules and controlled ileal release capsules

    H. Möllmann, M. Wagner, A. Tromm, A. Möllmann +4 more

    19981 citations

    Semantic Scholar

    Save

11. Influence of food uptake on the pharmacokinetics and systemic effects after single application of budesonide pH-modified release capsules

    S. Homrighausen, M. Wagner, H. Möllmann, A. Möllmann +4 more

    19980 citations

    Semantic Scholar

    Save

12. Systemic availability and pharmacodynamic effects after multiple rectal administration of budesonide foam in healthy volunteers

    M. Wagner, H. Möllmann, A. Tromm, P. Froehlich +5 more

    19980 citations

    Semantic Scholar

    Save

13. FLUTICASON, EIN NEUES INHALATIVES GLUCOCORTICOID

    H. Möllmann, M. Wagner, J. Barth

    19960 citations

    Semantic Scholar

    Save